SI-1004

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSI-1004
Drug Alias NameSI-1004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9
Therapy Area/IndicationsHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSolvotrin Innovations Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSolvotrin Innovations Ltd
Active IndicationsN/A
Inactive IndicationsHeart Diseases

Other Information

ATC CodeN/A
Related LinksN/A